LYELL IMMUNOPHARMA IN
1.1400
08-10月-24 10:44:58
15 分の遅延
株式
+0.0100
+0.88%
本日の幅
1.1200 - 1.1698
ISIN
N/A
ソース
NASDAQ
-
04 10 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
24 9 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in September Investor Conferences
28 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
07 8 2024 16:05:01 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
03 6 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
07 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
06 5 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
05 3 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
28 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in March Investor Conferences
26 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 1 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
09 11 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
07 11 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
31 10 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
27 9 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
11 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Upcoming Investor Conferences
31 8 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
08 8 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
05 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >